Ahmed Metwally

Dr. Ahmed Metwally

Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RRRavi Ranjan
Ravi Ranjan
ARAsha Rani
Asha Rani
Ahmed MetwallyAhmed Metwally
Ahmed Metwally
HMHalvor S. McGee
Halvor S. McGee
DPDavid L. Perkins
David L. Perkins

29 May 2019 in Nature
Verified
Journal Article
Open access
PDF file
WZWenyu Zhou
Wenyu Zhou
MSM. Reza Sailani
M. Reza Sailani
KCKévin Contrepois
Kévin Contrepois
YZYanjiao Zhou
Yanjiao Zhou
SASara Ahadi
Sara Ahadi
MSMichael P Snyder
Michael P Snyder
Type 2 diabetes mellitus (T2D) is a growing health problem, but little is known about its early disease stages, its effects on biological processes or the transition to clinical T2D. To understand the earliest stages of T2D better, we obtained samples from 106 healthy individuals and individuals with prediabetes over approximately four years and performed deep profiling of transcriptomes, metabolomes, cytokines, and proteomes, as well as changes in the microbiome. This rich longitudinal data set revealed many insights: first, healthy profiles are distinct among individuals while displaying diverse patterns of intra- and/or inter-personal variability. Second, extensive host and microbial changes occur during respiratory viral infections and immunization, and immunization triggers potentially protective responses that are distinct from responses to respiratory viral infections. Moreover, during respiratory viral infections, insulin-resistant participants respond differently than insulin-sensitive participants. Third, global co-association analyses among the thousands of profiled molecules reveal specific host–microbe interactions that differ between insulin-resistant and insulin-sensitive individuals. Last, we identified early personal molecular signatures in one individual that preceded the onset of T2D, including the inflammation markers interleukin-1 receptor agonist (IL-1RA) and high-sensitivity C-reactive protein (CRP) paired with xenobiotic-induced immune signalling. Our study reveals insights into pathways and responses that differ between glucose-dysregulated and healthy individuals during health and disease and provides an open-access data resource to enable further research into healthy, prediabetic and T2D states.

11 September 2023 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
DHDaniel Hornburg
Daniel Hornburg
SWSi Wu
Si Wu
MMMahdi Moqri
Mahdi Moqri
XZXin Zhou
Xin Zhou
Kevin ContrepoisKevin Contrepois
Kevin Contrepois
MSMichael P Snyder
Michael P Snyder
Lipids can be of endogenous or exogenous origin and affect diverse biological functions, including cell membrane maintenance, energy management and cellular signalling. Here, we report >800 lipid species, many of which are associated with health-to-disease transitions in diabetes, ageing and inflammation, as well as cytokine–lipidome networks. We performed comprehensive longitudinal lipidomic profiling and analysed >1,500 plasma samples from 112 participants followed for up to 9 years (average 3.2 years) to define the distinct physiological roles of complex lipid subclasses, including large and small triacylglycerols, ester- and ether-linked phosphatidylethanolamines, lysophosphatidylcholines, lysophosphatidylethanolamines, cholesterol esters and ceramides. Our findings reveal dynamic changes in the plasma lipidome during respiratory viral infection, insulin resistance and ageing, suggesting that lipids may have roles in immune homoeostasis and inflammation regulation. Individuals with insulin resistance exhibit disturbed immune homoeostasis, altered associations between lipids and clinical markers, and accelerated changes in specific lipid subclasses during ageing. Our dataset based on longitudinal deep lipidome profiling offers insights into personalized ageing, metabolic health and inflammation, potentially guiding future monitoring and intervention strategies.

29 November 2021 in Nature Medicine
Verified
Journal Article
Open access
PDF file
AAArash Alavi
Arash Alavi
GBGireesh K. Bogu
Gireesh K. Bogu
MWMeng Wang
Meng Wang
EREkanath Srihari Rangan
Ekanath Srihari Rangan
ABAndrew W. Brooks
Andrew W. Brooks
MSMichael P Snyder
Michael P Snyder
Early detection of infectious diseases is crucial for reducing transmission and facilitating early intervention. In this study, we built a real-time smartwatch-based alerting system that detects aberrant physiological and activity signals (heart rates and steps) associated with the onset of early infection and implemented this system in a prospective study. In a cohort of 3,318 participants, of whom 84 were infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), this system generated alerts for pre-symptomatic and asymptomatic SARS-CoV-2 infection in 67 (80%) of the infected individuals. Pre-symptomatic signals were observed at a median of 3 days before symptom onset. Examination of detailed survey responses provided by the participants revealed that other respiratory infections as well as events not associated with infection, such as stress, alcohol consumption and travel, could also trigger alerts, albeit at a much lower mean frequency (1.15 alert days per person compared to 3.42 alert days per person for coronavirus disease 2019 cases). Thus, analysis of smartwatch signals by an online detection algorithm provides advance warning of SARS-CoV-2 infection in a high percentage of cases. This study shows that a real-time alerting system can be used for early detection of infection and other stressors and employed on an open-source platform that is scalable to millions of users.

11 May 2020 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Open access
DRDerek Reiman
Derek Reiman
Ahmed MetwallyAhmed Metwally
Ahmed Metwally
JSJun Sun
Jun Sun
YDYang Dai
Yang Dai
Accurate prediction of the host phenotype from a metagenomic sample and identification of the associated microbial markers are important in understanding potential host-microbiome interactions related to disease initiation and progression. We introduce PopPhy-CNN, a novel convolutional neural network (CNN) learning framework that effectively exploits phylogenetic structure in microbial taxa for host phenotype prediction. Our approach takes an input format of a 2D matrix representing the phylogenetic tree populated with the relative abundance of microbial taxa in a metagenomic sample. This conversion empowers CNNs to explore the spatial relationship of the taxonomic annotations on the tree and their quantitative characteristics in metagenomic data. We show the competitiveness of our model compared to other available methods using nine metagenomic datasets of moderate size for binary classification. With synthetic and biological datasets, we show the superior and robust performance of our model for multi- class classification. Furthermore, we design a novel scheme for feature extraction from the learned CNN models and demonstrate improved performance when the extracted features. PopPhy-CNN is a practical deep learning framework for the prediction of host phenotype with the ability of facilitating the retrieval of predictive microbial taxa.

2 June 2023 in Science
Verified
Journal Article
Closed access
PFPetko P. Fiziev
Petko P. Fiziev
JMJeremy McRae
Jeremy McRae
JUJacob C. Ulirsch
Jacob C. Ulirsch
JDJacqueline S. Dron
Jacqueline S. Dron
THTobias Hamp
Tobias Hamp
KFKyle Kai-How Farh
Kyle Kai-How Farh
We examined 454,712 exomes for genes associated with a wide spectrum of complex traits and common diseases and observed that rare, penetrant mutations in genes implicated by genome-wide association studies confer ~10-fold larger effects than common variants in the same genes. Consequently, an individual at the phenotypic extreme and at the greatest risk for severe, early-onset disease is better identified by a few rare penetrant variants than by the collective action of many common variants with weak effects. By combining rare variants across phenotype-associated genes into a unified genetic risk model, we demonstrate superior portability across diverse global populations compared with common-variant polygenic risk scores, greatly improving the clinical utility of genetic-based risk prediction.